Overall, our study has shown that PD-L1CON cells have many similarities to melanoma cell lines and patient tumours that exhibit intrinsically upregulated PD-L1 expression following the development of resistance to MAPK pathway inhibitors via non-mutational and/or epigenetic mechanisms. The gene discussed is CD274; the disease is neoplasm.